Clinical trial
Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma
NCT00038389 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Vioxx and Radiation Therapy for Brainstem Glioma
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- October 31, 2001
- Completion date
- January 31, 2005
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.